A single- or multi-layered peptide compound — engineered layer by layer for the best chemistry, binding affinity and shelf life.
In horology, the tourbillon is a mechanism that spins the escapement to counter gravity — an elegant answer to a hard problem, the mark of a master watchmaker. Peptourbillon™ brings that same pursuit of precision to peptide science: many delicate parts, held in perfect relation, working as one.
Where a watch's tourbillon protects timekeeping from gravity, Peptourbillon protects a multi-peptide formulation from itself — so several peptides, each with its own chemistry, can share a single cartridge and a single injection without ever degrading one another.
Combining peptides is where good ideas go to spoil. Put several in one solution and they fight — the strengths of one become the undoing of another.
The answer is not to mix them better. It is to keep them apart until the instant they are used.
A multi-layered Peptourbillon is assembled the way a jeweller sets stones — one at a time, each secured before the next. The peptides are lyophilized in stages, so they only ever meet when the patient reconstitutes them.
Each layer is frozen while ultrasound prevents cavitation — giving uniform ice-crystal formation, because cavitation would damage delicate peptide structure.
The next peptide is laid onto the frozen layer just before the eutectic point, within a tight temperature window — so the layer below stays solid while the new one integrates, and no two peptides ever mix while wet.
Only once every layer is built and frozen down does lyophilization begin — preserving each layer as its own distinct, stable phase.
The drying stage uses fine-tuned radiofrequency to target water and remove it gently — no excessive heat, no thermal degradation of the peptide backbone.
Encapsulation and layering set how and when each layer releases on reconstitution — so every peptide acts at its peak, in the right order.
A Peptourbillon is only as good as the technologies that build and protect it. Each is a Bogdan Dicoias invention; together they secure the compound's chemistry, binding affinity and shelf life.








Worth being precise: the Peptourbillon on this page is the compound — the layered peptide product. The Peptourbillon calculator is a separate tool, part of the S3Pulse™ system, that consults Dicoias Ψ™ and Panacea's other models to compute and deliver the recipes — the peptidic liquids and the P-EARLs™ — from which each compound is made. The calculator designs; the compound is the result.
What is Peptourbillon?
Panacea Bio Chem's single- or multi-layered peptide
compound — named after the horological tourbillon and built layer by layer through sequential
lyophilization, so several peptides live in one cartridge without degrading each other, engineered
for the best chemistry, binding affinity and shelf life.
How is a multi-layered Peptourbillon made?
Each layer is frozen individually
(ultrasound-assisted, for uniform ice), the next layer added near the eutectic point in a tight
temperature window so the frozen layer stays solid — only then does lyophilization begin, with
radiofrequency-assisted drying that removes water gently without thermal degradation.
Is Peptourbillon the same as the Peptourbillon calculator?
No. Peptourbillon is the
compound. The Peptourbillon calculator is a separate tool within S3Pulse™ that uses
Dicoias Ψ™ to compute the recipes for the peptidic liquids and P-EARLs™ that make each compound.
What role do buffers play in peptide formulations?
Buffers control pH, and pH strongly influences peptide charge, solubility and degradation rates. Buffer species can also interact with a peptide or other excipients, so formulation development considers both target pH and the chemical properties of the buffer itself. — sources: PubMed — Stability of therapeutic peptides in aqueous solutions
What role do excipients play in peptide formulations?
Excipients can stabilize peptides by controlling pH, reducing interface stress, supporting a glassy lyophilized matrix, limiting aggregation, adjusting tonicity or modifying viscosity. Their effect is not universally beneficial; compatibility must be established for the specific peptide and process. — sources: PubMed — Stability of therapeutic peptides in aqueous solutions, PubMed — Factors affecting peptide aggregation
Recent developments in the field — refreshed 2026-10-09 by Panacea Bio Chem.
The Panacea Technology Universe
Proprietary Panacea Bio Chem Ltd technologies, invented by Bogdan Dicoias — what each one does, and why it leads its class.
Lyoprester®The only dual-chamber cartridge that is autoreconstitution-enabled, vacuum-sealed and argon-fillback.lyoprester.com ↗
P-EARLs™Panacea-Engineered Aseptic Reconstitution Liquid(s) — each tuned to the peptide it wakes.p-earls.com ↗
Peptourbillon™The layered peptide formulation architecture — single- or multi-layer, never a blend.peptourbillon.com ↗
RF Tunnel™The RF-formed central channel through the cake.rftunnel.com ↗
TgShift™Raises the cake’s glass-transition temperature with RF — instead of chilling below it.tgshift.com ↗
Cryolapse™Cryogenic pressure collapse under S3Pulse™ control — vapour redistributed through the whole cake, not its surface, impeding crust formation.cryolapse.com ↗
LyoLevit™The cake levitates and spins in high orbit — driven by ultrasound and RF.lyolevit.com ↗
Lyochrysalis™The integrated chamber housing the whole drying stack.lyochrysalis.com ↗
S3Pulse™The control brain for every piece of Panacea hardware.s3pulse.com ↗
Liquiprester™The single-liquid cartridge engineered so multiple peptide APIs coexist in one shared vehicle.liquiprester.com ↗
Syntheseract™Continuous-flow peptide synthesis in a special, very fast and economical way.syntheseract.com ↗
CFSPPS™Continuous-flow solid-phase peptide synthesis, written as its own category.cfspps.com ↗
OxyDeplete™Degassing plus no-headspace doctrine — the oxygen-starved seal.oxydeplete.com ↗
ArgonLock™The final inert-atmosphere lock under argon.argonlock.com ↗
RedoxVault™Separation, not merely suppression — redox isolation in lipid micro-reservoirs.redoxvault.com ↗
PleniDose™The shared filling gantry — one machine filling both the dual-chamber Lyoprester and the liquid Liquiprester.plenidose.com ↗
IncreSure™The dose-metrology layer — verified API per pen increment.incresure.com ↗
ElimiVoid™Front-void elimination without touching the metered dose.elimivoid.com ↗
Cryoviscous™The characterised cold, high-viscosity, low-mobility conditioning state.cryoviscous.com ↗
Vana Machine™Vacuum–Argon–Nitrogen Architecture — draws the air and nitrogen out of the cake and backfills with argon; in a separate process, the same machine makes the P-EARLs bubble-free.www.vanamachine.com ↗
EZnject™The disposable auto-injector pen built around the Lyoprester.panaceaeznject.com ↗
Dicoias ΨThe computed-chemistry advisory — every substance reduced to a vector across physical, electronic and formulation space.dcppsi.com ↗
SealoPrester™Aseptic Cartridge Closure System — Seal o’ Precision + Sterility.sealoprester.com ↗
Peptidic LiquidThe peptide formulation in solution — the active plus its buffers, cryoprotectants, lyoprotectants and scaffolders.peptidicliquid.com ↗
DiastolVAC™Biomimetic diastolic vacuum control — the pneumatic circulatory system of the machine: pumps, valves and sensors as one ensemble.diastolvac.com ↗Publications indexed in PubMed in the last 30 days for ("co-formulation"[tiab] OR "co-formulations"[tiab] OR coformulation[tiab] OR coformulations[tiab] OR "co-formulated"[tiab] OR coformulated[tiab] OR "fixed-ratio combination"[tiab] OR "fixed ratio combination"[tiab] OR "same syringe"[tiab] OR "single injection"[tiab] OR "physical compatibility"[tiab] OR "chemical compatibility"[tiab] OR "compatibility and stability"[tiab] OR admixture[tiab] OR admixtures[tiab] OR "mixed together"[tiab] OR "mixing of"[tiab] OR "co-delivery"[tiab] OR "co-encapsulation"[tiab] OR "co-lyophilization"[tiab] OR "co-lyophilized"[tiab]) AND (peptide[tiab] OR peptides[tiab] OR insulin[tiab] OR "GLP-1"[tiab] OR pramlintide[tiab] OR liraglutide[tiab] OR semaglutide[tiab] OR "insulin degludec"[tiab] OR IDegLira[tiab] OR iGlarLixi[tiab] OR cagrilintide[tiab] OR "growth hormone"[tiab]) AND (stability[tiab] OR formulation[tiab] OR formulations[tiab] OR lyophil*[tiab] OR "single injection"[tiab] OR "one injection"[tiab] OR compatib*[tiab] OR "dual-chamber"[tiab] OR "dual chamber"[tiab]) NOT (inhal*[tiab] OR canine[tiab] OR dog[tiab] OR dogs[tiab] OR oral[ti] OR tablet*[tiab] OR "case report"[tiab] OR "real-world"[tiab] OR "cost"[ti] OR nanomotor*[tiab]) — refreshed weekly.